reglab/housing_qa huggingface dataset:
NV Rev Stat § 422.387 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.387 - Calculation of disproportionate share payments; verification of eligibility for disproportionate share payments; Director authorized to negotiate terms of amendment to State Plan for Medicaid with Centers for Medicare and Medicaid Services of United States Department of Health and Human Services.

  1. The State Plan for Medicaid must provide the methodology for:  (a) Calculating the initial distribution of the disproportionate share payments in accordance with the regulations adopted pursuant to NRS 422.390;  (b) Adjusting the disproportionate share payment to a hospital if the annual audit of the hospital demonstrates that the disproportionate share payment made to the hospital was greater than the amount of money which the hospital was eligible to receive; and  (c) Redistributing any amount of disproportionate share payments which are returned to the Division as a result of the adjustments made in accordance with paragraph (b).  2. The State Plan for Medicaid or, if the Division deems necessary, the Division may require a hospital to submit any documentation or other information to verify eligibility for a disproportionate share payment or compliance with the requirements of NRS 422.380 to 422.390, inclusive. A disproportionate share payment may not be calculated for or made to a hospital which fails to provide the Division with documentation or other information that is required by the State Plan for Medicaid or the Division.  3. Except as otherwise provided in subsection 4, the State Plan for Medicaid must be consistent with the provisions of NRS 422.380 to 422.390, inclusive, and the regulations adopted pursuant thereto, and Title XIX of the Social Security Act, 42 U.S.C. §§ 1396 et seq., and the regulations adopted pursuant to those provisions.  4. If the Centers for Medicare and Medicaid Services of the United States Department of Health and Human Services denies an amendment to the State Plan for Medicaid, the Director may negotiate terms which are acceptable to the Centers for Medicare and Medicaid Services which are inconsistent with the provisions of NRS 422.380 to 422.390, inclusive, and the regulations adopted pursuant thereto if:  (a) Negotiating such terms is necessary to ensure that the State Plan for Medicaid is consistent with the provisions of Title XIX of the Social Security Act, 42 U.S.C. §§ 1396 et seq., and the regulations adopted pursuant to those provisions; and  (b) Before finalizing such an amendment to the State Plan for Medicaid, the Director obtains the approval of the Interim Finance Committee.  (Added to NRS by 1991, 2335; A 1993, 1969; 1995, 1428, 1430; 1997, 1244, 2631; 1999, 2242; 2001, 3116; 2003, 2992; 2005, 22nd Special Session, 36; 2009, 2294)
NV Rev Stat § 422.390 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.390 - Regulations; quarterly report.

  1. The Division shall adopt regulations concerning:  (a) Procedures for the intergovernmental transfers of money from the counties to the Division for the purposes of carrying out the provisions of NRS 422.380 to 422.390, inclusive, and the State Plan for Medicaid.  (b) Provisions for the payment of a penalty and interest for a delinquent intergovernmental transfer.  (c) Provisions for the payment of interest by the Division for late reimbursements to hospitals or other providers of medical care.  (d) Provisions for the calculation of disproportionate share payments for hospitals.  (e) Any required documentation of and reporting by a hospital relating to the calculation of the disproportionate share payment for the hospital and the verification of the disproportionate share payment that has been received by the hospital.  (f) Procedures and requirements for conducting independent and certified audits of hospitals and the disproportionate share payments made to hospitals as required pursuant to Title XIX of the Social Security Act, 42 U.S.C. §§ 1396 et seq., and the regulations adopted pursuant to those provisions.  (g) Procedures for adjusting a disproportionate share payment in accordance with Title XIX of the Social Security Act, 42 U.S.C. §§ 1396, et seq., and the regulations adopted pursuant to those provisions, if the audit of a hospital demonstrates that a disproportionate share payment made to the hospital was greater than the amount of money the hospital was eligible to receive.  (h) Procedures for redistributing any disproportionate share payment returned to the Division by a hospital in accordance with Title XIX of the Social Security Act, 42 U.S.C. §§ 1396 et seq., and the regulations adopted pursuant to those provisions.  2. The Division shall report to the Interim Finance Committee quarterly concerning the provisions of NRS 422.380 to 422.390, inclusive.  3. Notwithstanding the provisions of NRS 233B.039 to the contrary, the regulations adopted pursuant to this section must be adopted in accordance with the provisions of chapter 233B of NRS and must be codified in the Nevada Administrative Code.  (Added to NRS by 1991, 2337; A 1993, 1970; 1995, 1429; 1997, 2631; 1999, 2242; 2003, 2994; 2005, 22nd Special Session, 38; 2009, 2297)
NV Rev Stat § 422.396 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.396 - Establishment and administration of program to provide community-based services; application for federal waiver to amend State Plan for Medicaid; contracting for services; adoption of regulations.

  1. The Department, through a division of the Department designated by the Director, shall establish and administer a program to provide community-based services necessary to enable a person with a physical disability to remain in his or her home or with his or her family and avoid placement in a facility for long-term care. The Department shall coordinate the provision of community-based services pursuant to this section.  2. The Department shall apply to the Secretary of Health and Human Services for a waiver granted pursuant to 42 U.S.C. § 1396n(c) that authorizes the Department to amend the State Plan for Medicaid adopted by the Department pursuant to NRS 422.063 in order to authorize the Department to include as medical assistance under the State Plan the following services for persons with physical disabilities:  (a) Respite care;  (b) Habilitation;  (c) Residential habilitation;  (d) Environmental modifications;  (e) Supported living;  (f) Supported living habilitation;  (g) Supported personal care; and  (h) Any other community-based services approved by the Secretary of Health and Human Services.  The Department shall cooperate with the Federal Government in obtaining a waiver pursuant to this subsection.  3. The Department may use personnel of the Department or it may contract with any appropriate public or private agency, organization or institution to provide the community-based services necessary to enable a person with a physical disability to remain in his or her home or with his or her family and avoid placement in a facility for long-term care.  4. A contract entered into with a public or private agency, organization or institution pursuant to subsection 3 must:  (a) Include a description of the type of service to be provided;  (b) Specify the price to be paid for each service and the method of payment; and  (c) Specify the criteria to be used to evaluate the provision of the service.  5. The Department shall adopt regulations necessary to carry out the provisions of this section, including, without limitation, the criteria to be used in determining eligibility for the services provided pursuant to the program. Before adopting regulations pursuant to this section, the Department shall solicit comments from persons with a variety of disabilities and members of the families of those persons.  6. As used in this section, "person with a physical disability" means a person with a severe physical disability that substantially limits his or her ability to participate and contribute independently in the community in which the person lives.  (Added to NRS by 1997, 2659; A 2003, 2622; 2013, 1622)
NV Rev Stat § 422.3962 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.3962 - Amendment of home and community-based services waiver to include as medical assistance under Medicaid funding of assisted living supportive services for senior citizens who reside in certain assisted living facilities.

  1. The Department shall apply to the Secretary of Health and Human Services to amend its home and community-based services waiver granted pursuant to 42 U.S.C. § 1396n. The waiver must be amended, in addition to providing coverage for any home and community-based services which the waiver covers on June 4, 2005, to authorize the Department to include as medical assistance under Medicaid the funding of assisted living supportive services for senior citizens who reside in assisted living facilities which are certified by the Housing Division of the Department of Business and Industry pursuant to NRS 319.147.  2. The Department shall:  (a) Cooperate with the Federal Government in amending the waiver pursuant to this section;  (b) If the Federal Government approves the amendments to the waiver, adopt regulations necessary to carry out the provisions of this section, including, without limitation, the criteria to be used in determining eligibility for the assisted living supportive services funded pursuant to subsection 1; and  (c) Implement the amendments to the waiver only to the extent that the amendments are approved by the Federal Government.  3. As used in this section:  (a) "Assisted living facility" means a residential facility for groups that:  (1) Satisfies the requirements set forth in subsection 7 of NRS 449.0302; and  (2) Has staff at the facility available 24 hours a day, 7 days a week, to provide scheduled assisted living supportive services and assisted living supportive services that are required in an emergency in a manner that promotes maximum dignity and independence of residents of the facility.  (b) "Assisted living supportive services" means services which are provided at an assisted living facility to residents of the assisted living facility, including, without limitation:  (1) Personal care services;  (2) Homemaker services;  (3) Chore services;  (4) Attendant care;  (5) Companion services;  (6) Medication oversight;  (7) Therapeutic, social and recreational programming; and  (8) Services which ensure that the residents of the facility are safe, secure and adequately supervised.  (Added to NRS by 2005, 922) — (Substituted in revision for NRS 422.2708)
NV Rev Stat § 422.3964 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.3964 - State Plan for Medicaid: Inclusion of certain home and community-based services. [Effective January 1, 2020.]

  1. The Director shall include in the State Plan for Medicaid an option to provide certain additional home and community-based services in a manner consistent with 42 U.S.C. § 1396n(i). To the extent authorized by federal law, the Division shall provide tenancy support services to assist recipients of Medicaid pursuant to that option.  2. The Division shall adopt any regulations necessary to comply with the requirements of 42 U.S.C. § 1396n(i).  3. As used in this section, "tenancy support services" means services authorized pursuant to federal law that assist a recipient of Medicaid in obtaining and remaining in housing the Division determines to be adequate.  (Added to NRS by 2019, 3106, effective January 1, 2020)
NV Rev Stat § 422.401 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.401 - Definitions.

As used in NRS 422.401 to 422.406, inclusive, unless the context otherwise requires, the words and terms defined in NRS 422.4015 to 422.4024, inclusive, have the meanings ascribed to them in those sections.  (Added to NRS by 2003, 1317; A 2017, 1801, 3928; 2019, 2167, 4028)
NV Rev Stat § 422.4015 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4015 - "Committee" defined. [Effective through December 31, 2019.]

Committee means the Pharmacy and Therapeutics Committee established pursuant to NRS 422.4035.  (Added to NRS by 2003, 1317)
NV Rev Stat § 422.4015 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4015 - "Board" defined. [Effective January 1, 2020.]

Board means the Silver State Scripts Board established pursuant to NRS 422.4035.  (Added to NRS by 2003, 1317; A 2019, 4028, effective January 1, 2020)
NV Rev Stat § 422.402 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.402 - "Drug Use Review Board" defined.

Drug Use Review Board means the Board established pursuant to 42 U.S.C. § 1396r-8(g)(3).  (Added to NRS by 2003, 1317)
NV Rev Stat § 422.4021 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4021 - Health benefit plan" defined. [Effective January 1, 2020.]

Health benefit plan means a policy, contract, certificate or agreement offered to provide, deliver, arrange for, pay for or reimburse any of the costs of health care services.  (Added to NRS by 2019, 4027, effective January 1, 2020)
NV Rev Stat § 422.4022 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4022 - "Health maintenance organization" defined. [Effective January 1, 2020.]

Health maintenance organization has the meaning ascribed to it in NRS 695C.030.  (Added to NRS by 2019, 4027, effective January 1, 2020)
NV Rev Stat § 422.4023 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4023 - "Pharmacy benefit manager" defined. [Effective January 1, 2020.]

Pharmacy benefit manager has the meaning ascribed to it in NRS 683A.174.  (Added to NRS by 2019, 4027, effective January 1, 2020)
NV Rev Stat § 422.4024 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4024 - "Sickle cell disease and its variants" defined.

Sickle cell disease and its variants has the meaning ascribed to it in NRS 439.4927.  (Added to NRS by 2019, 2167)
NV Rev Stat § 422.4025 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4025 - List of preferred prescription drugs used for Medicaid program; list of drugs excluded from restrictions; role of Pharmacy and Therapeutics Committee; availability of new pharmaceutical products and products for which there is new evidence. [Effective through December 31, 2019.]

  1. The Department shall, by regulation, develop a list of preferred prescription drugs to be used for the Medicaid program.  2. The Department shall, by regulation, establish a list of prescription drugs which must be excluded from any restrictions that are imposed on drugs that are on the list of preferred prescription drugs established pursuant to subsection 1. The list established pursuant to this subsection must include, without limitation:  (a) Atypical and typical antipsychotic medications that are prescribed for the treatment of a mental illness of a patient who is receiving services pursuant to Medicaid;  (b) Prescription drugs that are prescribed for the treatment of the human immunodeficiency virus or acquired immunodeficiency syndrome, including, without limitation, protease inhibitors and antiretroviral medications;  (c) Anticonvulsant medications;  (d) Antirejection medications for organ transplants;  (e) Antidiabetic medications;  (f) Antihemophilic medications; and  (g) Any prescription drug which the Committee identifies as appropriate for exclusion from any restrictions that are imposed on drugs that are on the list of preferred prescription drugs.  3. The regulations must provide that the Committee makes the final determination of:  (a) Whether a class of therapeutic prescription drugs is included on the list of preferred prescription drugs and is excluded from any restrictions that are imposed on drugs that are on the list of preferred prescription drugs;  (b) Which therapeutically equivalent prescription drugs will be reviewed for inclusion on the list of preferred prescription drugs and for exclusion from any restrictions that are imposed on drugs that are on the list of preferred prescription drugs; and  (c) Which prescription drugs should be excluded from any restrictions that are imposed on drugs that are on the list of preferred prescription drugs based on continuity of care concerning a specific diagnosis, condition, class of therapeutic prescription drugs or medical specialty.  4. The list of preferred prescription drugs established pursuant to subsection 1 must include, without limitation, any prescription drug determined by the Committee to be essential for treating sickle cell disease and its variants.   5. The regulations must provide that each new pharmaceutical product and each existing pharmaceutical product for which there is new clinical evidence supporting its inclusion on the list of preferred prescription drugs must be made available pursuant to the Medicaid program with prior authorization until the Committee reviews the product or the evidence.  (Added to NRS by 2003, 1317; A 2010, 26th Special Session, 36; 2011, 985; 2015, 2158; 2017, 2174; 2019, 2167)
NV Rev Stat § 422.4026 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4026 - Coverage of certain supplements for treating sickle cell disease and its variants. [Effective through December 31, 2019.]

  1. The Department, upon the recommendation of the Committee, shall prescribe by regulation a list of nonprescription supplements essential for treating sickle cell disease and its variants that must be covered by Medicaid for recipients who have sickle cell disease and its variants.  2. The Committee shall review the list of supplements prescribed pursuant to subsection 1 at least biennially to determine whether to recommend adding or removing any supplements from the list and report those recommendations to the Department.  (Added to NRS by 2019, 2167)
NV Rev Stat § 422.4026 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4026 - Coverage of certain supplements for treating sickle cell disease and its variants. [Effective January 1, 2020.]

  1. The Department, upon the recommendation of the Board, shall prescribe by regulation a list of nonprescription supplements essential for treating sickle cell disease and its variants that must be covered by Medicaid for recipients who have sickle cell disease and its variants.  2. The Board shall review the list of supplements prescribed pursuant to subsection 1 at least biennially to determine whether to recommend adding or removing any supplements from the list and report those recommendations to the Department.  (Added to NRS by 2019, 2167, effective January 1, 2020)
NV Rev Stat § 422.403 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.403 - Establishment and management of use by Medicaid program of step therapy and prior authorization; duties of Drug Use Review Board; acceptance of recommendations from Board. [Effective through December 31, 2019.]

  1. The Department shall, by regulation, establish and manage the use by the Medicaid program of step therapy and prior authorization for prescription drugs.  2. The Drug Use Review Board shall:  (a) Advise the Department concerning the use by the Medicaid program of step therapy and prior authorization for prescription drugs;  (b) Develop step therapy protocols and prior authorization policies and procedures for use by the Medicaid program for prescription drugs; and  (c) Review and approve, based on clinical evidence and best clinical practice guidelines and without consideration of the cost of the prescription drugs being considered, step therapy protocols used by the Medicaid program for prescription drugs.  3. The Department shall not require the Drug Use Review Board to develop, review or approve prior authorization policies or procedures necessary for the operation of the list of preferred prescription drugs developed for the Medicaid program pursuant to NRS 422.4025.  4. The Department shall accept recommendations from the Drug Use Review Board as the basis for developing or revising step therapy protocols and prior authorization policies and procedures used by the Medicaid program for prescription drugs.  (Added to NRS by 2003, 1318)
NV Rev Stat § 422.403 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.403 - Establishment and management of use by Medicaid program of step therapy and prior authorization; duties of Drug Use Review Board; acceptance of recommendations from Board. [Effective January 1, 2020.]

  1. The Department shall, by regulation, establish and manage the use by the Medicaid program of step therapy and prior authorization for prescription drugs.  2. The Drug Use Review Board shall:  (a) Advise the Department concerning the use by the Medicaid program of step therapy and prior authorization for prescription drugs;  (b) Develop step therapy protocols and prior authorization policies and procedures for use by the Medicaid program for prescription drugs; and  (c) Review and approve, based on clinical evidence and best clinical practice guidelines and without consideration of the cost of the prescription drugs being considered, step therapy protocols used by the Medicaid program for prescription drugs.  3. The Department shall not require the Drug Use Review Board to develop, review or approve prior authorization policies or procedures necessary for the operation of the list of preferred prescription drugs developed pursuant to NRS 422.4025.  4. The Department shall accept recommendations from the Drug Use Review Board as the basis for developing or revising step therapy protocols and prior authorization policies and procedures used by the Medicaid program for prescription drugs.  (Added to NRS by 2003, 1318; A 2019, 4029, effective January 1, 2020)
NV Rev Stat § 422.4035 (2021)
2021 Nevada Revised Statutes|Chapter 422 - Health Care Financing and Policy|NRS 422.4035 - Pharmacy and Therapeutics Committee: Creation; membership. [Effective through December 31, 2019.]

  1. The Director shall create a Pharmacy and Therapeutics Committee within the Department. The Committee must consist of at least 5 members and not more than 11 members appointed by the Governor based on recommendations from the Director.  2. The Governor shall appoint to the Committee health care professionals who have knowledge and expertise in one or more of the following:  (a) The clinically appropriate prescribing of outpatient prescription drugs that are covered by Medicaid;  (b) The clinically appropriate dispensing and monitoring of outpatient prescription drugs that are covered by Medicaid;  (c) The review of, evaluation of and intervention in the use of prescription drugs; and  (d) Medical quality assurance.  3. At least one-third of the members of the Committee must be active physicians licensed to practice medicine in this State, at least one of whom must be an active psychiatrist licensed to practice medicine in this State. At least one-third of the members of the Committee must be either active pharmacists registered in this State or persons in this State with doctoral degrees in pharmacy.  4. A person must not be appointed to the Committee if the person is employed by, compensated by in any manner, has a financial interest in, or is otherwise affiliated with a business or corporation that manufactures prescription drugs.  (Added to NRS by 2003, 1318; A 2015, 304)